English 
Deutsch 
Dr. Sennewald named as distributor for Novac7 mobile linear accelerator 
The Gold Standard in Hyperthermia 
Novac7 – The first mobile electron linear accelerator for IORT 
Malignant melanoma
In 1996, the results of a multi-centric Phase III study with recurrent or metastasizing malignant melanoma (performed by Overgaard, Aarhus, Denmark, et.al.) was published in the International Journal of Hyperthermia. The study showed that hyperthermia combined with radiation therapy increased the complete remission rate from 35% to 62% and recurrence-free survival after 5 years from 28% to 46% compared to radiation therapy alone (refer to vol. 12, no. 1, pp. 3-20).
Udo Gaipl: Immunological and biological rationale for hyperthermia in cancer treatment